|
|
Polyarteritis Nodosa
Alternate Names : Periarteritis Nodosa
 See all Pictures & Images
Polyarteritis Nodosa Prognosis (Expectations)
Treatment is mandatory for long-term survival. Without treatment, survival is poor. However, with current treatments using steroids and other drugs that suppress the immune system (such as cyclophosphamide), improvements are seen both in the symptoms as well as in the survival rate. The most serious associated conditions generally involve the kidneys and gastrointestinal tract.
Today's Top News Stories | • | Early Elective C-Sections Produce Complications - Jan 07, 2009, 17:00
Babies delivered at 37 weeks have double the troubles of those born at 39 weeks.
| • | Gene Governs Response to Leukemia Chemotherapy - Jan 07, 2009, 17:00
Acute lymphoblastic leukemia is most common pediatric cancer. | • | Teen Birth Rate Up in 26 States in 2006 - Jan 07, 2009, 14:00
Highest rates in South, Southwest; lowest rates in Northeast, government reports. | • | Clinical Trials Update: Jan. 7, 2009 - Jan 07, 2009, 09:58
- Hypertension (High Blood Pressure)
- Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
- Memory Loss
| • | Study of Everest Climbers Questions Oxygen Use - Jan 07, 2009, 17:00
Whether low levels would work for ER patients with hypoxia remains unclear. |
|
Jump to another section
• Definition
• Polyarteritis Nodosa Overview, Causes, & Risk Factors
• Polyarteritis Nodosa Symptoms & Signs
• Polyarteritis Nodosa Prevention
• Polyarteritis Nodosa Diagnosis & Tests
• Polyarteritis Nodosa Treatment
• Polyarteritis Nodosa Prognosis
• Polyarteritis Nodosa Complications
• Calling Your Health Care Provider
• Pictures & Images
Topics that might be of interest to you Diseases & Conditions
• Acute Kidney Failure
• Heart Attack
• Intestinal Ischemia and Infarction
• Stroke
Tests & Exams
• Biopsy
• CBC
• ESR
• WBC Count
Other Topics
• Abdominal Pain
• Appetite - Decreased
• Fatigue
• Fever
• Joint Pain
• Muscle Aches
• Weakness
• Weight Loss - Unintentional
Review Date : 8/2/2002
Reviewed By : Birgit Kovacs, M.D., Immunology Division, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT. Review provided by VeriMed Healthcare Network.
|
|
